Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5582/bst.2020.03058 http://scihub22266oqcxt.onion/10.5582/bst.2020.03058 32249257!ä!32249257 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biosci+Trends 2020 ; 14 (2): 159-160 Nephropedia Template TP {{tp|p=32249257|t=2020. Macrolide treatment for COVID-19: Will this be the way forward?|pdf=|usr=}}{{32249257}} gab.com Text Macrolide treatment for COVID-19: Will this be the way forward JO: Biosci Trends http://www.kidney.de/pget.php?&tw=1&pmid=32249257 #FOAvip The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that has developed in late 2019 and 2020 is a serious threat to human health. With no vaccines or drugs approved for prevention and treatment until now, all efforts at drug design and/or clinical trials of already approved drugs are worthy and creditable. Using structure-based drug selection for identification of SARS-CoV-2 protease inhibitors, old drugs such as macrolides (MAC) were predicted to be effective for COVID-19. Lately, the anti-viral effects of macrolides have attracted considerable attention. Very recently, hydroxychloroquine in combination with azithromycin treatment was reported to be effective for COVID-19. We believe that treatments with macrolides alone or in combination with other drugs are promising and open the possibility of an international strategy to fight this emerging viral infection. Twit Text FOAVip Macrolide treatment for COVID-19: Will this be the way forward ????Biosci Trends http://www.kidney.de/pget.php?&tw=1&pmid=32249257 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32249257 #FOAvip English Wikipedia <ref>{{Cite pmid|32249257}}</ref> Macrolide treatment for COVID-19: Will this be the way forward? #MMPMID32249257 Ohe M; Shida H; Jodo S; Kusunoki Y; Seki M; Furuya K; Goudarzi H Biosci Trends 2020[May]; 14 (2): 159-160 PMID32249257show ga The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that has developed in late 2019 and 2020 is a serious threat to human health. With no vaccines or drugs approved for prevention and treatment until now, all efforts at drug design and/or clinical trials of already approved drugs are worthy and creditable. Using structure-based drug selection for identification of SARS-CoV-2 protease inhibitors, old drugs such as macrolides (MAC) were predicted to be effective for COVID-19. Lately, the anti-viral effects of macrolides have attracted considerable attention. Very recently, hydroxychloroquine in combination with azithromycin treatment was reported to be effective for COVID-19. We believe that treatments with macrolides alone or in combination with other drugs are promising and open the possibility of an international strategy to fight this emerging viral infection. |Antiviral Agents/chemistry/pharmacology[MESH] |Betacoronavirus/*drug effects/enzymology/isolation & purification[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/*drug therapy/epidemiology/virology[MESH] |Humans[MESH] |Macrolides/chemistry/*pharmacology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy/epidemiology/virology[MESH] |Protease Inhibitors/chemistry/pharmacology[MESH] |SARS-CoV-2[MESH]Macrolide treatment for COVID-19: Will this be the way forward?(epmc).pdf DeepDyve Pubget Overpricing